Atovaquone is an antiprotozoal drug used to treat and prevent malaria. However, during the manufacturing process, impurities may be formed that can affect the quality, safety, and efficacy of the drug. These impurities can be identified and quantified through analytical methods, and their levels must be controlled within acceptable limits to ensure the drug's quality and safety.
